Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Factor V Preliminary

Coagulation

Coagulation Factor VFactor V activity assayFV

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the activity of Factor V, a protein made in the liver that helps your blood clot properly. It is part of the coagulation cascade, which is the series of steps your body uses to stop bleeding after an injury. The result reflects how well Factor V is functioning in your plasma at the time of collection.

A preliminary Factor V result is often part of an initial workup when a bleeding or clotting problem is suspected. It can help direct whether more detailed testing is needed, such as specific factor studies, inhibitor evaluations, or broader assessments of liver function and overall clotting.

Why it matters

Your clinician may order this test if you have unusual bleeding, easy bruising, a prolonged clotting time, or if there is concern for a disorder that affects clotting proteins. It can help identify whether there is a Factor V deficiency, whether Factor V is being consumed during an illness, or whether there might be an inhibitor that interferes with Factor V function. It is also considered when assessing liver health, because many clotting factors are produced in the liver.

Results can guide treatment decisions, such as replacing missing factors, addressing underlying conditions, or planning procedures safely. Understanding your Factor V activity can also help distinguish inherited issues from changes caused by medications or acute illnesses, which supports a personalized approach to your care.

Understanding your results

If your Factor V activity is lower than expected, it may suggest a deficiency, reduced production, increased consumption, or the presence of an antibody that interferes with Factor V function. Your care team may recommend repeat testing, additional factor assays, or studies that look for inhibitors to clarify the cause. If liver disease or an inflammatory condition is suspected, tests that evaluate those conditions may be done alongside your clotting studies.

If your activity is higher than expected, it is usually not harmful by itself but can occur with certain physiological states or laboratory conditions. Your clinician will interpret the result together with your bleeding history, medications, and other coagulation tests. Do not change or stop any medication without medical advice; instead, discuss the next steps, which may include confirmatory testing or monitoring over time.

Reference ranges

0.51.5 U/mL
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Factor V Preliminary

  • Sample collection and handling

    Underfilling the blue-top citrate tube, delays in processing, or improper storage can falsely alter activity results. Ensure the blood draw is performed carefully and the sample reaches the lab promptly.

  • Heparin or direct oral anticoagulants

    Medications such as heparin or certain direct anticoagulants can interfere with clot-based assays and may lower apparent activity. Tell your clinician about all blood thinners you take.

  • Liver function and systemic illness

    Because Factor V is produced in the liver, liver disease can reduce activity. Severe infections, disseminated intravascular coagulation, or major surgery can also consume clotting factors and affect results.

  • Inherited vs acquired conditions

    Inherited Factor V deficiency lowers activity, while some antibodies can inhibit Factor V function. Additional tests, such as inhibitor screens or other factor assays, may be needed to distinguish causes.

  • Pregnancy and hormonal influences

    Physiologic changes during pregnancy and with estrogen-containing therapies can shift coagulation dynamics and may influence interpretation. Your clinician will consider this context when reviewing results.

  • Lupus anticoagulant and assay interference

    Some antiphospholipid antibodies can prolong clotting-based tests or cause variable factor assay results. If suspected, specialized testing can help avoid misinterpretation.

  • Recent transfusion

    Transfusion of plasma products can temporarily change measured factor activities. Let the laboratory know about any recent transfusions so timing and interpretation are appropriate.

  • Age and clinical context

    Factor levels can vary with age and health status. Your result is best interpreted alongside your medical history, physical findings, and other coagulation tests.

2026

References

  1. McGill University Health Centre. (2016, March 17). Factor V Preliminary (Task CD 18461554). Laboratory reference ranges.
  2. Clinical and Laboratory Standards Institute. (2014). Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays (5th ed., CLSI document H21-A5). CLSI.
  3. Kitchen, S., McCraw, A., & Echenagucia, M. (2014). Diagnosis of hemophilia and other bleeding disorders: A laboratory manual (2nd ed.). World Federation of Hemophilia.